1.The experimental study on the relationship between the hepatic glycogen content and the liver transplantation of non-heart-beating donor
Tang-Lei SHAO ; Wei-Ping YANG ; Wei-Yao CAI ;
Chinese Journal of Organ Transplantation 2005;0(12):-
Objective To study whether the warm ischemia-reperfusion injury can be alleviated if the hepatic glycogen content were increased before liver transplantation.Methods The male SD rats as donors and recipients were divided into groups A,B and C randomly.In group A,the rats were al- lowed access to solid and water ad libitum;In group B,the rats drank glucose liquor for 4 days prior to liver harvesting;In group C,the rats were intravenously injected with 50% glucose besides the protocol in group B 3-4 h prior to liver harvesting.According to the non-heart-beating time(the non- heart-beating time were set into 60,90,120 and 150 min),the rats in groups A,B and C were divided into 4 subgroups,and the orthotopic liver transplantation was performed and the hepatic glycogen and ATP contents were measured.The one-week survival rate and the serum levels of MDA and SOD in the recipients were determined after liver transplantation.Results The hepatic glycogen and ATP con- tents in groups B and C were more than those in group A significantly(P
2.Relationship between MnSOD polymorphisms and susceptibility of chronic poisoning exposed to manganism occupationally.
Shao-lei CAI ; Ming-xia SUN ; Yong-jian YAN ; Xiao-guang SUN ; Bin LIN ; Ji-hua FU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2011;29(3):206-208
OBJECTIVETo study the relationship between polymorphisms of MnSOD and the susceptibility of chronic poisoning exposed to manganism occupationally.
METHODSIn a study of case-control, genotypes were determined by PCR-RFLP in 164 patients with chronic occupational mangamism poisoning and 328 controls with age- and sex-matched for MnSOD 9Ala-Val.
RESULTSThere was a significant difference in the frequency of MnSOD 9Ala-Val at V locus mutant allele between cases and controls (χ(2) = 15.225, P < 0.01, 95%CI = 1.43 ∼ 3.00). Individuals with the genotype VV had a 1.30 of risk increase of occupational chronic manganism poisoning compared with the the genotype AV or AA (OR = 2.30, 95%CI = 1.52 ∼ 3.49, P < 0.05).
CONCLUSIONThe MnSOD polymorphisms may be related with the susceptibility to chronic occupational manganism poisoning, the risk of chronic occupational manganism poisoning increases in carriers with genotype VV at MnSOD 9Ala-Val locus.
Adult ; Case-Control Studies ; Female ; Genetic Predisposition to Disease ; Genotype ; Humans ; Male ; Manganese Poisoning ; genetics ; Middle Aged ; Occupational Diseases ; genetics ; Occupational Exposure ; Polymorphism, Single Nucleotide ; Superoxide Dismutase ; genetics
4.Relationship between mRNA expression of MnSOD and manganese neurotoxicity.
Xiao-li FAN ; Yong-jian YAN ; Shao-lei CAI ; Yue-ling HE ; Ming-gang ZHANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2013;31(12):886-888
OBJECTIVETo investigate the relationship between mRNA expression of manganese superoxide dismutase (MnSOD) and manganese neurotoxicity.
METHODSThirty-one patients with occupational chronic manganese poisoning (case group), as well as 31 controls exposed to the same condition (control group), were included in the study. Whole blood RNA was extracted, and the mRNA expression of MnSOD was measured by RT-PCR; the two groups were compared in terms of the mRNA expression of MnSOD. PC12 cells were treated with 0, 100, 200, 400, 600, 800, and 1000 ümol/L MnCl₂ for l, 2, 3, and 4 d; the cell viability was determined by MTT assay, and the mRNA expression of MnSOD was measured by RT-PCR.
RESULTSThe case group had significantly lower mRNA expression of MnSOD than the control group (0.390 ± 0.080 vs 0.582 ± 0.219, P < 0.05). MnCl2 had a toxic effect on PC12 cells; the concentration of MnCl₂ was positively correlated with the toxic effect but negatively correlated with the mRNA expression of MnSOD.
CONCLUSIONMnSOD mRNA may be involved in the manganese-induced damage of nerve cells. It is hypothesized that high mRNA expression of MnSOD may play an inhibitory effect on manganese neurotoxicity.
Adult ; Animals ; Female ; Gene Expression ; Humans ; Male ; Manganese Poisoning ; genetics ; Middle Aged ; Neurotoxicity Syndromes ; genetics ; PC12 Cells ; RNA, Messenger ; genetics ; Rats ; Superoxide Dismutase ; genetics
6.Experimental study on the phenotype of human embryonic lung fibroblasts transfected with Ad-BMP-2.
Lei WANG ; Shao-hua LIU ; Mei ZHANG ; Xun QU ; Feng-cai WEI
West China Journal of Stomatology 2006;24(3):257-260
OBJECTIVETo investigate the effects on the phenotype, especially the mineralization ability of human embryonic lung fibroblasts(HELFs) by transfection with adenovirus vector ecoding human bone morphogenetic protein-2 gene (Ad-BMP-2).
METHODSThe HELFs were primarily cultured, then transfected with Ad-BMP-2. The morphologic characteristics of the cells were observed. The cell proliferation, alkaline phosphatase activities, BMP-2 protein expression, and the mineralization ability were detected with the methods of MTT, ALP staining, Western blot, and alizarin red S staining, respectively.
RESULTSAfter transfection, the shape of HELFs changed from silm spindle to multifigure, the cells became bigger than before. The colonies changed from unilaminar into multilaminar. The proliferation of HELFs was severely inhibited after transfection. An obvious BMP-2 lane was shown in Western blotting. Most cells presented positive in ALP staining, and large number of nacarat mineralized nodes were observed after alizarin red S staining.
CONCLUSIONHELFs were capable of transforming into osteoblast-like phenotype, and were endowed with the ability of mineralization while being transfected with Ad-BMP-2.
Bone Morphogenetic Protein 2 ; Bone Morphogenetic Proteins ; Cell Proliferation ; Fibroblasts ; Genetic Vectors ; Humans ; Osteoblasts ; Osteogenesis ; Phenotype ; Transfection ; Transforming Growth Factor beta
7.Studies on pharmacodynamic characteristics of aristolochic acid I in rats.
Tao SU ; Lei QU ; Chun-li ZHANG ; Shao-qing CAI ; Xiao-mei LI
China Journal of Chinese Materia Medica 2004;29(7):676-681
OBJECTIVETo study pharmacodynamic characteristics by oral administration aristolochic acid I (AA-I) in rats.
METHODAfter one-time oral administration of Aristolochiae manshuriensis decoction 10 g x kg(-1) and 125I labeled AA-I (containing AA-I 37.2 microg x mL(-1)), whole blood concentration of 125I-AA-I and the binding rate of serum albumin were detected in 69 normal wistar male rats. Metabolic dynamic parameters were calculated by program 3P87 with a two compartment model. The distribution ratio and ID% of nine viscera or tissue were measured and compared with other until the 40th day.
RESULTAfter oral administration, AA-I was rapidly absorbed into the blood and reached its peak at 30 minutes and lasted till 90 minutes. AA-I concentration in the blood gradually declined afterwards. 24 hours later, only few AA-I could be detected. By the 10th day, 68.5% of AA-I presented as the binding type with serum albumin. Pharmacodynamic parameters were calculated as follows: Tmax 0.74 h, Cmax 0.92 microg x mL(-1), t1/2alpha 0.68 h, t1/2beta 20.46 h, V/F 87.39 mL, CL(s) 5.85 mL x h(-1) (0.10 mL x min(-1)). On the other hand, after oral administration AA-I was rapidly distributed to all the viscera or tissue, whose peak appeared in 5 minutes and the vallecula was from 24 to 48 hours. The distribution ratio of AA-I rose in the kidney after 24 hours, and it showed the highest level in the kidney and in the liver by the 4th day compared with other organs or tissue (P < 0.05). However, the distribution ratio of AA-I in the kidney became the most dominant one after the 30th and the 40th day compared with the others (P < 0.05).
CONCLUSIONAA-I is rapidly absorbed after oral administration in rats. Its distribution has the organ specificity, which is characterized as the possible partial metabolism in the liver and the accumulation in the kidney because of rather slower elimination. The characteristics may be related to the long term nephrotoxicity of AA-I.
Administration, Oral ; Animals ; Aristolochia ; chemistry ; Aristolochic Acids ; administration & dosage ; pharmacokinetics ; pharmacology ; Kidney ; metabolism ; Liver ; metabolism ; Male ; Metabolic Clearance Rate ; Plants, Medicinal ; chemistry ; Rats ; Rats, Wistar ; Tissue Distribution
8.Application of elastic intramedullary nail in treating bilateral femoral shaft fractures in children.
Wei LIAO ; Pan CAI ; Ding-yun ZHAO ; Shao-kun WU ; Sun-fang YAN ; Lei YANG
China Journal of Orthopaedics and Traumatology 2010;23(8):621-623
OBJECTIVETo explore the curative effects and complications of elastic intramedullary nail in treating children's bilateral femoral shaft fractures.
METHODSForm February 2005 to March 2008, 7 patients with bilateral femoral shaft fractures were treated by closed reduction and internal fixation with elastic intramedullary nail. There were 5 males and 2 females. The age ranged from 3 to 13 years with the mean of 8.3 years. Six injuries caused by road accident and 1 injury caused by fall from high. Two cases associated with pulmonary contusion, 3 cases brain injuries, 1 case fracture of calcaneus and 1 case bladder injuries. All the cases were closed fractures without nerve and blood vessel injury. A cast external fixation had been used after operation for a month in two cases.
RESULTSAll the patients were followed up for 21-37 months with an average of 30.3 months. No infecton of incisional wound, displacement fracture, internal fixation fail, delayedunion and malunion were found. All fracture obtained healing for 7-12 weeks with an average of 8.7 weeks. Inequality of lower limb was found in 1 case (length differences was 5 mm). According to Flynn scoring,all fractures were excellent.
CONCLUSIONTreatment of femoral shaft fractures in children with elastic intramedullary nail according with biological principle. The method has little trauma, less complication, outstanding effect and it is a good way to treat bilateral femoral shaft fractures result from high-energy injuries.
Adolescent ; Bone Nails ; Child ; Child, Preschool ; Elasticity ; Female ; Femoral Fractures ; surgery ; Fracture Fixation, Intramedullary ; adverse effects ; methods ; Humans ; Male
9.Studies on solid phase extraction method of aristolochic acids and aristololactams in rat urine.
Dian-Hong ZHAO ; Lei QU ; Xuan WANG ; Xiao-Mei LI ; Jun-Yu XU ; Shao-Qing CAI
China Journal of Chinese Materia Medica 2007;32(24):2613-2619
OBJECTIVETo develop a urine pretreatment method of Solid Phase Extraction (SPE) for the quantitative determination of a number of aristolochic acids (AAs) and aristololactams (ALs) in rat urine.
METHODThe HPLC peak area of AA-I , AA-II, AL-I and AL-II, and other sixteen AAs and ALs was chosen as evaluating index to study the extract results of five Solid Phase Extraction columns (Agilent C18/100 mg, Alltech HG18/100 mg, Alltech C18/100 mg, Alltech C18/300 mg and Agilent Phenyl/200 mg) comparatively. The influences of two washing solvents (water and 1% acetic acid-0.02% triethylamine solution) and seven eluting solvents (ether, acetone, chloroform, ethyl acetate, dichloromethane, methanol and acetonitrile) on extract results of AAs and ALs are comparatively studied with the extracting recoveries of AA-I , AA-II, AL-I and AL-II as indicators. The HPLC peak area of AA-I , AA-II, AL-I and AL-II, and other seven AAs and ALs with good separation being targets, several factors which affect extracting efficiency of analytes, including activating volume, cleansing volume, washing volume and eluting volume, are optimized by orthogonal design experiments with four factors at three levels.
RESULTThe established method of SPE is as follows: Agilent Phenyl SPE column of 200 mg, activating with 1.0 mL methanol, cleansing with 1 mL water, adding 1.0 mL rat urine sample, washing with 0.8 mL 1% acetic acid 0.02% triethylamine solution, and eluting with 3.0 mL methanol.
CONCLUSIONThe established method of SPE is efficient, selective, simple and fast, and can be used as urine pretreatment method to analyze a variety of aristolochic acids and aristololactams in rat urine.
Administration, Oral ; Animals ; Aristolochia ; chemistry ; Aristolochic Acids ; urine ; Chromatography, High Pressure Liquid ; methods ; Drugs, Chinese Herbal ; administration & dosage ; isolation & purification ; pharmacokinetics ; Male ; Random Allocation ; Rats ; Rats, Wistar ; Solid Phase Extraction ; methods
10.Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.
Song LIN ; Nan-nan SHAO ; Lei FAN ; Xiu-cai MA ; Fei-fei PU ; Zeng-wu SHAO
Journal of Huazhong University of Science and Technology (Medical Sciences) 2014;34(6):889-895
Studies have proved that microRNA-101 (miR-101) functions as a tumor suppressor and is associated with growth and apoptosis of various human cancers. However, the role of miR-101 in osteosarcoma and the possible mechanism by which miR-101 affects the tumor growth and apoptosis have not been fully elucidated. In this study, we found that the expression of miR-101 was down-regulated in osteosarcoma tissues and Saos-2 cell line as compared with that in adjacent non-neoplastic bone tissues and the osteoblastic cell line. To better characterize the role of miR-101 in osteosarcoma, we used a gain-of-function analysis by transfecting human osteosarcoma cell line Saos-2 with chemically synthesized miR-101 mimics. The results showed that overexpression of miR-101 inhibited the proliferation and promoted the apoptosis of Saos-2 cells. Meanwhile, bioinformatic analysis demonstrated that mTOR gene was a direct target of miR-101. Overexpression of miR-101 significantly decreased the expression of mTOR at both mRNA and protein levels in Saos-2 cells, consequently inhibiting Saos-2 cells proliferation and promoting cells apoptosis in an mTOR-dependent manner. Taken together, these data suggest that miR-101 may act as a tumor suppressor, which is commonly downregulated in both osteosarcoma tissues and cells. mTOR plays an important role in mediating miR-101 dependent biological functions in osteosarcoma. Reintroduction of miR-101 may be a novel therapeutic strategy by down-regulating mTOR expression.
Apoptosis
;
Bone Neoplasms
;
genetics
;
metabolism
;
pathology
;
Cell Line, Tumor
;
Cell Proliferation
;
Humans
;
MicroRNAs
;
genetics
;
metabolism
;
Neoplasm Proteins
;
genetics
;
metabolism
;
Osteosarcoma
;
genetics
;
metabolism
;
pathology
;
RNA, Neoplasm
;
genetics
;
metabolism
;
TOR Serine-Threonine Kinases
;
genetics
;
metabolism